Literature DB >> 9712370

Coadministration of IL-12 or IL-10 expression cassettes drives immune responses toward a Th1 phenotype.

J J Kim1, H C Maguire, L K Nottingham, L D Morrison, A Tsai, J I Sin, A A Chalian, D B Weiner.   

Abstract

Cytokines are important regulators of the immune response. They influence immune expression, the development of immunologic memory, and regulation of antigen-specific and nonspecific immune activation as well as allergic responses. In a model system in mice, we have studied the effect of plasmids expressing interleukin (IL)-10 or IL-12 on the modulation of antigen-specific responses. Coadministration of IL-12 or IL-10 genes with DNA immunogens directed the antigen-specific immune response toward a T helper (Th1)-type immunity. In addition to the modulation of antigen-specific immune responses, we studied the induction of delayed-type hypersensitivity (DTH) to contact allergens as an in vivo model of the Th1 response. We found that IL-12 and IL-10 gene-containing plasmids, and not the bacterial plasmid alone, upregulate this response. Our cytokine gene delivery technique demonstrates an important level of control of the magnitude and direction of induced immune responses and could be advantageous in a wide variety of immunotherapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9712370     DOI: 10.1089/jir.1998.18.537

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  10 in total

1.  A chimeric HIV-1 envelope glycoprotein trimer with an embedded granulocyte-macrophage colony-stimulating factor (GM-CSF) domain induces enhanced antibody and T cell responses.

Authors:  Thijs van Montfort; Mark Melchers; Gözde Isik; Sergey Menis; Po-Ssu Huang; Katie Matthews; Elizabeth Michael; Ben Berkhout; William R Schief; John P Moore; Rogier W Sanders
Journal:  J Biol Chem       Date:  2011-04-22       Impact factor: 5.157

2.  Unique Th1/Th2 phenotypes induced during priming and memory phases by use of interleukin-12 (IL-12) or IL-28B vaccine adjuvants in rhesus macaques.

Authors:  Matthew P Morrow; Jian Yan; Panyupa Pankhong; Bernadette Ferraro; Mark G Lewis; Amir S Khan; Niranjan Y Sardesai; David B Weiner
Journal:  Clin Vaccine Immunol       Date:  2010-08-04

3.  Comparative ability of IL-12 and IL-28B to regulate Treg populations and enhance adaptive cellular immunity.

Authors:  Matthew P Morrow; Panyupa Pankhong; Dominick J Laddy; Kimberly A Schoenly; Jian Yan; Neil Cisper; David B Weiner
Journal:  Blood       Date:  2009-03-20       Impact factor: 22.113

4.  DNA vaccines encoding DEC205-targeted antigens: immunity or tolerance?

Authors:  Thomas Niezold; Michael Storcksdieck Genannt Bonsmann; André Maaske; Vladimir Temchura; Vanessa Heinecke; Drew Hannaman; Jan Buer; Christina Ehrhardt; Wiebke Hansen; Klaus Überla; Matthias Tenbusch
Journal:  Immunology       Date:  2015-04-30       Impact factor: 7.397

5.  IL-28B/IFN-lambda 3 drives granzyme B loading and significantly increases CTL killing activity in macaques.

Authors:  Matthew P Morrow; Jian Yan; Panyupa Pankhong; Devon J Shedlock; Mark G Lewis; Kendra Talbott; Roberta Toporovski; Amir S Khan; Niranjan Y Sardesai; David B Weiner
Journal:  Mol Ther       Date:  2010-06-22       Impact factor: 11.454

6.  Robust antibody and cellular responses induced by DNA-only vaccination for HIV.

Authors:  Stephen C De Rosa; Srilatha Edupuganti; Yunda Huang; Xue Han; Marnie Elizaga; Edith Swann; Laura Polakowski; Spyros A Kalams; Michael C Keefer; Janine Maenza; Yiwen Lu; Megan C Wise; Jian Yan; Matthew P Morrow; Amir S Khan; Jean D Boyer; Laurent Humeau; Scott White; Michael Pensiero; Niranjan Y Sardesai; Mark L Bagarazzi; David B Weiner; Guido Ferrari; Georgia D Tomaras; David C Montefiori; Lawrence Corey; M Juliana McElrath
Journal:  JCI Insight       Date:  2020-07-09

7.  Increasing a robust antigen-specific cytotoxic T lymphocyte response by FMDV DNA vaccination with IL-9 expressing construct.

Authors:  Qiang Zou; Bing Wu; Xiaodan He; Yizhi Zhang; Youmin Kang; Jin Jin; Hanqian Xu; Hu Liu; Bin Wang
Journal:  J Biomed Biotechnol       Date:  2010-04-27

8.  Intramuscular and Intradermal Electroporation of HIV-1 PENNVAX-GP® DNA Vaccine and IL-12 Is Safe, Tolerable, Acceptable in Healthy Adults.

Authors:  Srilatha Edupuganti; Stephen C De Rosa; Marnie Elizaga; Yiwen Lu; Xue Han; Yunda Huang; Edith Swann; Laura Polakowski; Spyros A Kalams; Michael Keefer; Janine Maenza; Megan C Wise; Jian Yan; Matthew P Morrow; Amir S Khan; Jean D Boyer; Laurent Humeau; Scott White; Niranjan Y Sardesai; Mark L Bagarazzi; Peter B Gilbert; James G Kublin; Lawrence Corey; David B Weiner
Journal:  Vaccines (Basel)       Date:  2020-12-07

9.  Construction and immunogenicity of a DNA vaccine coexpressing GP3 and GP5 of genotype-I porcine reproductive and respiratory syndrome virus.

Authors:  Jing-Qiang Ren; Wen-Chao Sun; Hui-Jun Lu; Shu-Bo Wen; Jie Jing; Fu-Long Yan; Hao Liu; Cun-Xia Liu; Peng-Peng Xiao; Xing Chen; Shou-Wen Du; Rui Du; Ning-Yi Jin
Journal:  BMC Vet Res       Date:  2014-06-10       Impact factor: 2.741

10.  Immune Therapy Targeting E6/E7 Oncogenes of Human Paillomavirus Type 6 (HPV-6) Reduces or Eliminates the Need for Surgical Intervention in the Treatment of HPV-6 Associated Recurrent Respiratory Papillomatosis.

Authors:  Charu Aggarwal; Roger B Cohen; Matthew P Morrow; Kimberly A Kraynyak; Albert J Sylvester; Jocelyn Cheung; Kelsie Dickerson; Veronique Schulten; Dawson Knoblock; Elisabeth Gillespie; Joshua M Bauml; Jian Yan; Malissa Diehl; Jean Boyer; Michael Dallas; J Joseph Kim; David B Weiner; Jeffrey M Skolnik
Journal:  Vaccines (Basel)       Date:  2020-01-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.